January 2023 in “Book of Abstracts” COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.
January 2018 in “Communications in computer and information science” This study developed a novel system that can automatically estimate hair loss parameters from images without expert input, reporting satisfactory results from testing on samples collected in Kolkata.
October 2017 in “The Journal of Urology” Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.
April 2014 in “Significance” Unconventional home remedies can sometimes show surprising results.
Online tools are effective and cost-efficient for recruiting dermatology research participants, especially among younger people.
The ProScope HR is an effective, user-friendly, and affordable tool for diagnosing hair loss.
June 2007 in “Endocrinology and Metabolism Clinics of North America” This study reports that incomplete information in a reverse supply chain can lead to efficiency losses, but a two-part tariff contract for the remanufacturer may improve performance by eliciting private information from collectors.
September 2003 in “Clinics in Family Practice” Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.
August 1994 in “Drugs & Therapy Perspectives” Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.
June 2026 in “International Journal of Ayurvedic Medicine (Hyderabad)” This study reviewed trichoscopic images to assess hair loss, finding that ayurvedic signs (lakshanas) aligned with modern trichoscopic parameters, potentially aiding accurate diagnosis and management of hair conditions.
June 2026 in “International Journal of Ayurvedic Medicine” In this study, researchers investigated the alignment of trichoscopic findings with ayurvedic signs (lakshanas) for diagnosing hair loss, suggesting that integrating these perspectives could enhance diagnostics and management of hair and scalp conditions.
February 2026 in “MedBA Medicine” This study identified potential new adverse drug reaction signals for erlotinib, used in lung and pancreatic cancer treatment, by analyzing a large dataset of case reports, indicating further clinical studies are necessary to confirm these findings.
February 2026 in “Frontiers in Pharmacology” This review suggests a shift toward genetically informed treatments for male pattern hair loss by integrating genetic insights and pharmacogenetic markers into therapeutic decision-making.
January 2026 in “International Journal of Science and Research (IJSR)” In this study, artificial intelligence's integration into Indian aesthetic medicine has expanded from consumer apps to crucial roles in diagnostics, treatment planning, and clinic management, driven by demands for precise data over subjective opinions and enhancing competitive advantage.
This study highlights that azelaic acid, initially recognized for skin hypopigmentation, shows potential in treating various skin conditions due to its complex mechanisms, even though these are not yet fully understood, indicating a need for further research.
In this case report, researchers describe a 22-year-old male with a unique presentation of Senior-Løken Syndrome due to a NPHP4 mutation, exhibiting atypical symptoms like cryptorchidism, alopecia, and potential syndromic overlap with Rothmund-Thomson Syndrome, suggesting complex genetic interactions and expanding the phenotypic spectrum of ciliopathies.
December 2024 in “arXiv (Cornell University)” In this study, researchers devised a stochastic hair growth model influenced by regular haircuts, using a process that undergoes linear growth subject to random resets, and used it to theoretically determine an ideal haircut routine.
July 2024 in “Frontiers in Microbiology” Data-driven methods can help understand microbiota's role in diseases and develop personalized treatments.
May 2019 in “The Journal of Sexual Medicine” This study found that among premenopausal women taking flibanserin, consuming wine with an evening meal may increase the risk of syncope and orthostatic hypotension-related adverse events compared to placebo.
January 2019 in “ISGE series” This review discusses the criteria, diagnosis, and treatment options for polycystic ovary syndrome and reports no new clinical results; it highlights the need for further research on causative treatments.
December 2018 in “Lasers in Surgery and Medicine” This special issue reviews various advances in laser and light-based technologies for dermatological treatments, emphasizing improvements for diverse skin types, but reports no new empirical results.
January 2017 in “Brazilian Journal of Pharmaceutical Sciences” This study identified neprilysin as a potential target of the pharmacological agent arteannuin, which may guide future research into its clinical applications, although experimental verification is needed.
July 2016 in “Experimental Dermatology” This article provides clinical snippets from Experimental Dermatology and reports no new research findings.
July 2016 in “Journal of Investigative Dermatology” R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.
This article provides a reference guide for various dermatological terms, treatments, and conditions, but reports no new clinical findings.
July 2011 in “British Journal of Dermatology” Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.
April 2008 in “Australasian journal of dermatology” The book gives a basic overview of mesotherapy and fat-dissolving injections but lacks detailed guidance and effectiveness comparisons for practitioners.
January 2019 in “Springer eBooks” This chapter discusses procedural therapies like platelet-rich plasma and low-level light therapy for androgenetic alopecia, but reports no new clinical findings.
November 2003 in “Journal of Dermatology” Authors defend finasteride-depression link, suggest detailed medical history, and call for more investigation.
1 citations
,
January 2017 in “Expert opinion on orphan drugs” This study reviews current systemic treatments for hidradenitis suppurativa, highlighting traditional methods and new options like biological agents, and suggests that pharmacological therapies show promise, particularly for non-advanced cases, despite the disease's complex etiology involving factors such as genetics and inflammation.